Skip to content
Search

Latest Stories

PSNC calls for price concession fix as system is no longer working for pharmacy contractors

The Pharmaceutical Services Negotiating Committee (PSNC)’s members are seeking immediate rescue packages for the sector to help with energy bills and to ease capacity constraints.

In a meeting held on 14th and 15th September, the committee members expressed their anger and frustration on the reluctance of NHS England and government to fund pharmacy sustainably.


The meeting was held to consider practical steps to ease the pressures on the community pharmacy sector, and to oversee the progress of negotiations on the Community Pharmacy Contractual Framework (CPCF) and other work.

Committee members, as pharmacy contractors, shared their experiences of the current pressures on all contractors, including the inability to deliver some services and to maintain core service levels; the capacity and workforce crises facing the sector; the critical need for funding support this winter; and the urgent need for Government to adapt the Price Concessions system to meet the needs of contractors.

The Price Concessions system is no longer working for contractors in the current volatile medicine supply environment and PSNC is clear this is not acceptable,” said the committee.

“We have sent a strong and clear message back to Government that pharmacies cannot subsidise the NHS medicines bill, escalating this within the Department of Health and Social Care (DHSC) and insisting that they find urgent solutions.”

Over the reluctance of NHS England and Government to fund pharmacy sustainably, PSNC said, it ‘will lead the sector in holding them to account for this, including through the work to develop a new vision and strategy for the community pharmacy sector.’

A deal on Year 4 of the five-year CPCF was agreed in principle over the summer but is awaiting final cross-government approval following ministerial resignations in the summer.

The committee reconsidered this in light of the rapidly worsening economic outlook for community pharmacies.

The Committee also considered funding delivery, looked at key service-related consultations, and made early decisions on PSNC’s Transforming Pharmacy Representation (TAPR) work.

As part of the TAPR work, they considered key questions about PSNC’s governance – ahead of a full governance review – and contractor levies, and these will be discussed at the upcoming LPC Conference before announcements are made to contractors.

At the LPC Conference in Manchester this week (September 22), PSNC members and LPCs came together to explore further practical solutions to the pressures facing contractors and to look at how local and national representatives can best collaborate on those.

Prior to the meeting, PSNC chief executive Janet Morrison said: “PSNC’s committee members, all of whom are community pharmacy contractors or representatives of contractors, have this month reflected the anger and frustration that is being felt across the sector.

Pharmacies stepped up during the pandemic to deliver all that the government and NHS needed, yet you are now struggling to keep afloat while those same two organisations allow Drug Tariff and concession price issues, spiralling costs, and other pressures to decimate your businesses. This is not acceptable to us, it is not acceptable to NHS patients, and it won’t be acceptable to the public: PSNC is clear that policy-makers must be held to account for it.

“We are continuing to take a very hard line on all of these issues, alongside ramping up our influencing and data-gathering work as we seek short-term solutions for all contractors. During the pandemic we and the wider the sector fought very hard for contractors’ Covid costs to be covered and that is what we will do again now, with energy prices, with Price Concessions, and with overall funding levels. Thank you once again to all those contractors who have contacted us about these issues and for all the evidence you provide on an ongoing basis – we will be needing more of this soon.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less